Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.07404 | 76 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.24019 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.93474 | 75 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.22832 | 76 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.0077 | 75 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.57114 | 72 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.22071 | 78 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.07055 | 76 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.19236 | 77 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.86608 | 74 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.06752 | 76 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.25132 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.04434 | 76 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.07205 | 76 |